1-4 of 4
Authors: Jose Sanz
Sort by
Journal Article
Real-life data of immune recovery using bictegravir/emtricitabine/tenofovir alafenamide in virologically suppressed people living with HIV. Results at 48–96 weeks of RETROBIC Study Free
Jesús Troya and others
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 3, March 2024, Pages 595–607, https://doi.org/10.1093/jac/dkae011
Published: 24 January 2024
Journal Article
Dynamics of creatinine estimated glomerular filtration rate using one or more antiretrovirals that inhibit creatinine tubular secretion Free
Maria Jesus Perez Elias and others
Journal of Antimicrobial Chemotherapy, Volume 76, Issue 4, April 2021, Pages 1046–1050, https://doi.org/10.1093/jac/dkaa547
Published: 27 January 2021
Journal Article
Factors associated with the number of drugs in darunavir/cobicistat regimens Free
Esteban Martinez and others
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 1, January 2020, Pages 208–214, https://doi.org/10.1093/jac/dkz399
Published: 05 October 2019
Journal Article
Lipid disorders in antiretroviral-naive patients treated with lopinavir/ritonavir-based HAART: frequency, characterization and risk factors
Get access
Maria Luisa Montes and others
Journal of Antimicrobial Chemotherapy, Volume 55, Issue 5, May 2005, Pages 800–804, https://doi.org/10.1093/jac/dki063
Published: 01 May 2005
Advertisement intended for healthcare professionals
Advertisement intended for healthcare professionals